Clinical score and rapid antigen detection test to guide antiobiotic use for sore throats: Randomised controlled trial of PRISM (primary care streptoccal management)BMJ Online
Date of this Version10-10-2013
Document TypeJournal Article
AbstractObjective To determine the effect of clinical scores that predict streptococcal infection or rapid streptococcal antigen detection tests compared with delayed antibiotic prescribing. Design: Open adaptive pragmatic parallel group randomised controlled trial. Setting: Primary care in United Kingdom. Patients: Patients aged .3 with acute sore throat. Intervention: An internet programme randomised patients to targeted antibiotic use according to: delayed antibiotics (the comparator group for analyses), clinical score, or antigen test used according to clinical score. During the trial a preliminary streptococcal score (score 1, n=1129) was replaced by a more consistent score (score 2, n=631; features: fever during previous 24 hours; purulence; attends rapidly (within three days after onset of symptoms); inflamed tonsils; no cough/coryza (acronym FeverPAIN). Outcomes: Symptom severity reported by patients on a 7 point Likert scale (mean severity of sore throat/difficulty swallowing for days two to four after the consultation (primary outcome), duration of symptoms, use of antibiotics.
Citation InformationPaul Little, F.D.Richard Hobbs, Michael Moore, David Mant, et al.. "Clinical score and rapid antigen detection test to guide antiobiotic use for sore throats: Randomised controlled trial of PRISM (primary care streptoccal management)" BMJ Online (2013) ISSN: 1756-1833
Available at: http://works.bepress.com/paul_glasziou/114/